Health Wildcatters, a Dallas accelerator and INVEST Digital Health partner, has announced the healthcare startups in its latest cohort. Join us at INVEST DIgital Health on October 29 and meet them in person!
Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical information. Epic denied the claims — but the lawsuit highlights ongoing concerns about interoperability, data access and competition in the healthcare software space.
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
Six healthcare startups using AI to address a variety of healthcare challenges will vie for the top prize at the conference at Pegasus Park in Dallas on September 18. Register today!
There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.
Fourteen investors have committed to offering office hours at the HW Venture Center in July and August.
Dr. Tina Saw is the founder and CEO of Oral Genome, a healthcare startup that's developing saliva tests to detect and prevent oral diseases. In response to emailed questions, Saw talked about her company's approach.
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
The roster of speakers at INVEST Digital Health scheduled for September 18 in Dallas includes executives from health systems, healthcare entrepreneurs, and more. Register today!
Meeting individuals where they are in their healthcare journey is essential for keeping lines of communication open and creating the right conditions for people to proactively seek out diabetes care.
In a fireside chat at INVEST Digital Health in Dallas, Polsinelli Healthcare M&A Co-chair Jonathan Henderson and Jim Walton, President of JWalton LLC discussed the healthcare preferences of different generations and how they will impact caregiving.
The INVEST Digital Health conference in Dallas, a collaboration between MedCity News and the Health Wildcatters accelerator, spotlights a wide range of hot topics in digital health, a startup pitch contest focused on femtech, and networking opportunities with investors and healthcare stakeholders. Register today!
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Memorial Hermann Health System in Houston struck a new partnership with Midi Health, a virtual care clinic focused exclusively on women who are navigating menopause. The health system's two main goals for the partnership are to provide another point of access for its patients to manage their health at home and to gather data to inform decisions about which services it should offer to meet women’s healthcare needs.
The group of 10 startups in the accelerator have ambitions to improve early detection of lung cancer, eliminate contaminated needles, improve remote monitoring and provide new ways to treat head lice, among other goals.
Clinical trial design will be one of the topics discussed at the upcoming INVEST Digital Health conference in Dallas on October 26. THREAD Clinical Trial Design Director Noah Goodson highlighted some of the milestones the sector has seen in recent years.
Lexicon Pharmaceuticals drug Inpefa is now FDA-approved for heart failure. Inpefa is third in its class, but the biotech says its pill can reach a specific subset of patients, enabling it to stand apart from rival medicines from AstraZeneca and partners Eli Lilly and Boehringer Ingelheim.
The FDA has asked for more information about cardiac complications reported last year in a Phase 1 study for the Molecular Templates cancer drug, MT-0169. The partial clinical hold comes as the biotech works through a corporate restructuring as well as a second Nasdaq de-listing notice.